{"schema_version":"secwatch.filing_event.v1","accession":"0001683168-21-005361","form_type":"8-K","ticker":"SNOA","cik":"0001367083","company_name":"Sonoma Pharmaceuticals, Inc.","filed_at":"2021-11-09T23:59:59+00:00","discovered_at":"2026-05-14T18:04:12.256319+00:00","generated_at":"2026-06-28T10:33:38.997687+00:00","sec_items":["1.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"medium","headline":"Sonoma signs 20-year exclusive license & distribution deal with Dyamed for four Southeast Asian markets","bullets":["Exclusive rights for hypochlorous acid products (dermatology, eye, oral) in Singapore, Malaysia, Indonesia, and Thailand.","20-year term; Dyamed pays royalty and transfer prices (amounts redacted).","Minimum annual purchase commitments in USD for first 10 years (redacted).","Exclusive license to use Sonoma's Microcyn trademark in the Territory.","Dyamed responsible for regulatory approvals, marketing, and distribution at its own cost."],"urls":{"canonical":"https://secwatch.observer/filing/0001683168-21-005361","json":"https://secwatch.observer/filing/0001683168-21-005361.json","markdown":"https://secwatch.observer/filing/0001683168-21-005361.md","text":"https://secwatch.observer/filing/0001683168-21-005361.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1367083/000168316821005361/0001683168-21-005361-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1367083/000168316821005361/snoa_i8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-28T10:33:38.997687+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}